Inhibitory effect of uremic solutions on protein-DNA-complex formation of the vitamin D receptor and other members of the nuclear receptor superfamily

Journal of Cellular Biochemistry

Volumn 74, Issue 3, 1999, Pages 386-394

  Toell, Andrea ^a   Degenhardt, Stefan ^a   Grabensee, Bernd ^a   Carlberg, Carsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Nuclear hormone signaling; Protein DNA interaction; Renal failure; Vitamin D receptor; Vitamin D3

Indexed keywords

CELL NUCLEUS RECEPTOR; COLECALCIFEROL; DNA; PROTEIN; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR; VITAMIN D RECEPTOR;

ARTICLE; CONTROLLED STUDY; DNA PROTEIN COMPLEX; HEMODIALYSIS; HORMONE RESPONSIVE ELEMENT; HUMAN; KIDNEY FAILURE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROMOTER REGION; UREMIA;

DNA-BINDING PROTEINS; HUMANS; MULTIGENE FAMILY; MUTAGENESIS; PERITONEAL DIALYSIS; PYRIDOXAL PHOSPHATE; RECEPTORS, CALCITRIOL; RECEPTORS, RETINOIC ACID; RENAL DIALYSIS; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS; UREMIA;

EID: 0033197921     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990901)74:3<386::AID-JCB7>3.0.CO;2-1     Document Type: Article

References (37)

1. Akizawa T, Fukagawa M, Koshikawa S, Kurokawa K. 1993. Recent progress in management of secondary hyperparathyroidism of chronic renal failure. Curr Opin Nephrol Hypertens 2:558-565.
2. 3 receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int 35:19-23.
3. 3: interplay with retinoid and thyroid hormone signalling. Eur J Biochem 231:517-527.
4. Carlberg C. 1996a. The concept of multiple vitamin D pathways. J Invest Dermatol Symp Proc 1:10-14.
5. 3 receptor in the context of the nuclear receptor superfamily: the central role of retinoid X receptor. Endocrine 4:91-105.
6. 3. Crit Rev Eukaryot Gene Expr 8:19-42.
7. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, Hunziker W. 1993. Two nuclear signalling pathways for vitamin D. Nature 361:657-660.
8. Carlberg C, Hooft van Huijsduijnen R, Staple J, DeLamarter JF, Becker-André M. 1994. RZRs, a novel class of retinoid related orphan receptors that function as both monomers and homodimers. Mol Endocrinol 8:757-770.
9. Farsetti A, Desvergne B, Hallenbeck P, Robbins J, Nikodem VR. 1992. Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter. J Biol Chem 267:15784-15788.
10. Fukagawa M, Fukuda N, Yi H, Kurokawa K. 1995. Resistance to calcitriol as a cause of parathyroid hyperfunction in chronic renal failure. Nephrol Dial Transplant 10:316-319.
11. Fukagawa M, Kitoaka M, Kurokawa K. 1997. Renal failure and hyperparathroidism. In: Feldman D, Glorieux FH, Pike JW, editors. Vitamin D. San Diego: Academic Press, p 1227-1239.
12. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436-1443.
13. Glass CK. 1994. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocrine Rev 15:391-407.
14. Higgins PJ, Bunn HF. 1981. Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. J Biol Chem 256: 5204-5208.
15. Hsu CH, Patel SR. 1995. Altered vitamin D metabolism and receptor interaction with the target genes in renal failure: calcitriol receptor interaction with its target gene in renal failure. Curr Opin Nephrol Hypertens 4:302-306.
16. Jones G, Calverley MJ. 1993. A dialogue on analogues. Trends Endocrinol Metabol 4:297-303.
17. 3 receptor binding site found in the rat atrial natriuretic factor promoter. Biochem Biophys Res Commun 218:882-886.
18. 3 receptor and the retinoid X receptor on DNA. Nucleic Acids Res 25:4307-4313.
19. 3 dependency of vitamin D receptor-retinoid X receptor-vitamin D-responsive element complex formation. Arch Biochem Biophys 341:75-80.
20. 3 in the parathyroid glands of patients with renal failure. N Engl J Med 316:1573-1577.
21. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Cham-bon P, Evans RM. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835-839.
22. 3 receptors in experimental uremia. Kidney Int 32:350-353.
23. Moras D, Gronemeyer H. 1998. The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol 10:384-391.
24. 3 receptor. Biochem J 235:561-568.
25. 3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 87:9995-9999.
26. Patel SR, Ke H-Q, Vanholder R, Koenig RJ, Hsu CH. 1995. Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest 96:50-59.
27. Patel SR, Koenig RJ, Hsu CH. 1996. Effect of Schiff base formation on the function of the calcitriol receptor. Kidney Int 50:1539-1545.
28. Pols HAP, Birkenhäger JC, van Leeuven JPTM. 1994. Vitamin D analogues: from molecule to clinical application. Clin Endocrinol 40:285-291.
29. Reichel H, Norman AW. 1989. Systemic effects of vitamin D. Annu Rev Med 40:71-78.
30. Rhodes SJ, Chen R, DiMattia GE, Scully KM, Kalla KA, Lin S-C, Yu VC, Rosenfeld MG. 1993. A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. Genes Dev 7:913-932.
31. Ringoir S. 1997. An update on uremic toxins. Kidney Int 52:S2-S4.
32. Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennström B. 1986. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324: 635-640.
33. Schräder M, Danielsson C, Wiesenberg I, Carlberg C. 1996. Identification of natural monomeric response elements of the nuclear receptor RZR/ROR: they also bind COUP-TF. J Biol Chem 271:19732-19736.
34. 3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of VDR-RXR heterodimer-mediated transactivation. Mol Cell Biol 15:1154-1161.
35. Slatopolsky ES, Brown AJ. 1997. Vitamin D and renal failure. In: Feldman D, Glorieux FH, Pike JW, editors. Vitamin D. San Diego: Academic Press, p 849-865.
36. Walters MR. 1992. Newly identified actions of the vitamin D endocrine system. Endocrine Rev 13:719-764.
37. Welsh J, Simboli-Campbell M, Narvaez CJ, Tenniswood M. 1995. Role of apoptosis in the growth inhibitory effects of vitamin D in MCF-7 cells. Adv. Exp Med Biol 375:45-52.